Company page
Exelixis, Inc.
Exelixis, Inc. is a public company traded under the ticker EXEL in the American market. The company has a market capitalization of approximately $13.05 billion. Exelixis is focused on developing and commercializing innovative therapies for cancer treatment.
- Ticker
- EXEL:NASDAQ
- Asset type
- Stock
- Market cap
- $13.05B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD